Elranatamab
Elranatamab (PF-06863135) is an anti-CD3E/TNFRSF17 human IgG2κ monoclonal antibody[1]. Recommend Isotype Controls: Human IgG2 kappa, Isotype Control (HY-P99002) .
Product Specifications
CAS Number
[2408850-14-4]
Product Name Alternative
PF-06863135; RN-613
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/elranatamab.html
Purity
99.962
Smiles
[Elranatamab]
Molecular Weight
(145.441 kDa)
References & Citations
[1]Elranatamab
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
OR1038987-01 100 mg
4- (4,5-Dihydro-5-thioxo-1,3,4-oxadiazol-2-yl) -2- (phenylmethyl) -1 (2H) -phthalazinone
Ask
View Details OR1038987-02 250 mg
4- (4,5-Dihydro-5-thioxo-1,3,4-oxadiazol-2-yl) -2- (phenylmethyl) -1 (2H) -phthalazinone
Ask
View Details OR1038987-03 500 mg
4- (4,5-Dihydro-5-thioxo-1,3,4-oxadiazol-2-yl) -2- (phenylmethyl) -1 (2H) -phthalazinone
Ask
View Details